Acyclovir
- Product NDC
- 0472-0082
- 11-digit product format
- 004720082
- Labeler code
- 0472
- Product ID
- 0472-0082_6f58843b-1a91-42b4-b03c-7cad93c931d6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA074738
- Marketing category
- ANDA
- Marketing start
- 2002-09-03
- Substance
- ACYCLOVIR
- Active strength
- 200 mg/5mL
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acyclovir
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACYCLOVIR | 200 mg/5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | X4HES1O11F |
| Rxcui | 307730 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0472-0082-16 | Acyclovir | 473 mL in 1 BOTTLE | SUSPENSION | 473 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0472-0082-16 | ML - Milliliter | 0472-0082 | eade4ea7-b374-4a92-be34-c18472a48b89 | 1 | 2013-02-11 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ACYCLOVIR | ACTIVE INGREDIENT | X4HES1O11F | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| ACYCLOVIR | ACTIVE MOIETY | X4HES1O11F | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ACYCLOVIR SUSPENSION [ACTAVIS MID ATLANTIC LLC] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 307730 | acyclovir 200 MG in 5 mL Oral Suspension | PSN | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 7 |
| 307730 | acyclovir 40 MG/ML Oral Suspension | SCD | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 7 |
| 307730 | acyclovir 200 MG per 5 ML Oral Suspension | SY | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 7 |
| 307730 | acycycloguanosine 40 MG/ML Oral Suspension | SY | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 7 |
| 307730 | acyclovir 200 MG in 5 mL Oral Suspension | PSN | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 5 |
| 307730 | acyclovir 40 MG/ML Oral Suspension | SCD | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 5 |
| 307730 | acyclovir 200 MG per 5 ML Oral Suspension | SY | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 5 |
| 307730 | acycycloguanosine 40 MG/ML Oral Suspension | SY | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 5 |
| 307730 | acyclovir 200 MG in 5 mL Oral Suspension | PSN | 4032ce02-e2b3-d426-e063-6294a90ab6c9 | 1 |
| 307730 | acyclovir 40 MG/ML Oral Suspension | SCD | 4032ce02-e2b3-d426-e063-6294a90ab6c9 | 1 |
| 307730 | acyclovir 200 MG per 5 ML Oral Suspension | SY | 4032ce02-e2b3-d426-e063-6294a90ab6c9 | 1 |
| 307730 | acycycloguanosine 40 MG/ML Oral Suspension | SY | 4032ce02-e2b3-d426-e063-6294a90ab6c9 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0472-0082-16 | 00472008216 | 473 mL in 1 BOTTLE (0472-0082-16) | 473 ml | 2002-09-03 | 0000-00-00 | No | No | Current |